What is the recommended dose of Tamiflu (oseltamivir) for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oseltamivir (Tamiflu) Dosing for Children

For children ≥1 year old, oseltamivir dosing is weight-based: ≤15 kg receive 30 mg, >15-23 kg receive 45 mg, >23-40 kg receive 60 mg, and >40 kg receive 75 mg, administered twice daily for 5 days for treatment or once daily for 10 days for prophylaxis. 1

Weight-Based Dosing for Children ≥1 Year

The FDA-approved dosing strategy uses body weight to determine appropriate doses 1:

Treatment (twice daily for 5 days):

  • ≤15 kg (≤33 lb): 30 mg twice daily 2, 3, 1
  • >15-23 kg (>33-51 lb): 45 mg twice daily 2, 3, 1
  • >23-40 kg (>51-88 lb): 60 mg twice daily 2, 3, 1
  • >40 kg (>88 lb): 75 mg twice daily 2, 3, 1

Prophylaxis (once daily for 10 days):

  • Same weight-based doses as treatment, but administered once daily instead of twice daily 2, 1

Infants <1 Year Old

For infants younger than 1 year, age-based mg/kg dosing is recommended 4, 3:

Treatment (twice daily for 5 days):

  • 9-11 months: 3.5 mg/kg per dose twice daily 3, 5
  • 0-8 months (term infants): 3.0 mg/kg per dose twice daily 4, 3, 5
  • <3 months: 3.0 mg/kg per dose twice daily 4

Prophylaxis:

  • 3-11 months: 3.0 mg/kg once daily for 10 days 4
  • <3 months: Not recommended unless situation is judged critical due to limited safety data 4

Preterm Infants

Preterm infants require special dosing based on postmenstrual age (gestational age + chronological age) due to immature renal function 3, 6:

  • <38 weeks postmenstrual age: 1.0 mg/kg twice daily 3, 6
  • 38-40 weeks postmenstrual age: 1.5 mg/kg twice daily 3, 6
  • >40 weeks postmenstrual age: 3.0 mg/kg twice daily 3, 6

Formulation and Administration

Oral suspension is the preferred formulation for children who cannot swallow capsules 1:

  • Available as powder that pharmacists reconstitute to 6 mg/mL concentration 2, 1
  • Volume conversions: 30 mg = 5 mL, 45 mg = 7.5 mL, 60 mg = 10 mL, 75 mg = 12.5 mL 6, 1
  • Capsules (30 mg, 45 mg, 75 mg) can be opened and mixed with liquid if needed 6

Administer with food to improve tolerability, as nausea and vomiting occur in approximately 10% of patients 2, 6

Renal Impairment Adjustments

For children with creatinine clearance 10-30 mL/min 6:

  • Treatment: 75 mg once daily (instead of twice daily) for 5 days
  • Prophylaxis: 30 mg once daily OR 75 mg every other day for 10 days

Oseltamivir is not recommended for end-stage renal disease patients not on dialysis 1

Critical Timing Considerations

Treatment must be initiated within 48 hours of symptom onset for maximum effectiveness, reducing illness duration by 1-1.5 days and decreasing complications like acute otitis media by 44% 2, 1

Prophylaxis should begin within 48 hours of exposure to an infected individual 6, 1

Common Pitfalls to Avoid

  • Do not use age-based dosing for children ≥1 year when weight is known—weight-based dosing is more accurate 3
  • Do not underdose infants 12-23 months—research shows the 30 mg unit dose may be insufficient for some children in this age range, with 60% having subtherapeutic exposures 5
  • Do not use standard pediatric dosing for preterm infants—they require lower mg/kg doses due to immature renal clearance 4, 3
  • Do not withhold treatment while awaiting laboratory confirmation in high-risk patients—empiric treatment should be initiated based on clinical suspicion 6

References

Guideline

Oseltamivir Dosing Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oseltamivir Treatment Guidelines for Influenza A

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Oseltamivir Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.